ArticleOpen forum infectious diseases2023

Loss to Follow-up and Death Among Individuals With Newly Diagnosed Human Immunodeficiency Virus Receiving Dolutegravir-Based First-Line Antiretroviral Treatment in Eastern Ethiopia: Implications for 95% United Nations Targets.

Abdella Gemechu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.